当前位置: 首页 > 期刊 > 《中国医药科学》 > 2013年第21期
编号:13149663
输血医学的发展—从全血输血到成分输血(4)
http://www.100md.com 2013年11月1日 《中国医药科学》 2013年第21期
     [26] Wandt H,Wendelin K.Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies:an open-label,multicentre,randomised study[J].The Lancet,2012, 380(9850):1309-1316.

    [27] Teixeira PGR,Inaba K,Shulman K,et al.Impact of Plasma Transfusion in Massively Transfused Trauma Patients[J].Journal of Trauma-Injury Infection & Critical Care,2009,66(3):693-697.

    [28] 林力红.血液成分制品的安全输注[J].福建医学杂志,2005,27(4):157-158.

    [29] Sharma RR,Marwaha N.Leukoreduced blood components: Advantages and strategies for its implementation in developing countries[J].Asian journal of transfusion science,2010,4(1):3-8.

    [30] Fergusson D,Khanna MP,Tinmouth A,et al.Transfusion of leukoreduced red blood cells may decrease postoperative infections :two meta-analyses of randomized controlled trials[J]. Canadian Journal of Anesthesia,2004,51(5):417-425.

    [31] Nicholas G,Gina C,Mary H,et al. A policy case study of blood in Australia[J]. Social Science & Medicine,2010,71(9):1677-1682.

    (收稿日期:2013-09-17), 百拇医药(孙波 刘术臻 程聪)
上一页1 2 3 4